Lymphocytic Leukemia, Acute Clinical Trials
A listing of Lymphocytic Leukemia, Acute medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 14579 clinical trials
Calling all young people with ASTHMA!
Everyone's asthma is different, so new treatments are always needed. Doctors need people like you to join a new research study, to test a new investigational treatment. Can you help us?
- 1050 views
- 23 Nov, 2020
- 1 location
Obsessive-Compulsive Disorder
Care medications. Eligibility Criteria: It is required that all women of child-bearing potential (WOCBP) who are sexually active agree to use two methods of contraception for the
- 3819 views
- 07 Nov, 2020
- 1 location
Study in Parkinson Disease of Exercise
This study is a Phase 3 multi-site, randomized, evaluator-masked, study of endurance treadmill exercise on changes in the Movement Disorder Society-Unified Parkinson Disease Rating Scale (MDS-UPDRS) Part III score at 12 months among persons with early stage Parkinson disease. 370 participants will be randomly assigned to 2 groups: 1)60-65% HRmax …
- 0 views
- 04 Jun, 2021
- 8 locations
Sternal Cerclage (sternal bone closure after open heart surgery)
The purpose of the study is to learn which treatment option is better for patients who have multi-vessel coronary artery disease (blockages in more than one vessel supplying blood to the heart muscle).
- 1160 views
- 05 Feb, 2021
- 1 location
A Phase 2, Open-Label, Monotherapy, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement
This is an open-label, monotherapy study of INCB054828 in subjects with myeloid/lymphoid neoplasms with FGFR1 rearrangement. Subjects will receive a once daily (QD) dose of INCB054828 at 13.5 mg on a 2-week-on–therapy and 1-week-off–therapy schedule. With Protocol Amendment 3, the administration schedule will be adjusted, and newly enrolled subjects will …
- 79 views
- 14 Dec, 2020
- 35 locations
COVID-19 Treatment Trial: Investigational Medication as a Non-antiviral Immunomodulator
Day 1 of the study. Total of 230 subjects will be enrolled; half will receive CD24Fc and half will receive placebo. All subjects will be treated with the best available treatment. The follow up period
- 3991 views
- 17 Jun, 2020
- 4 locations
VAD00001: Respiratory Syncytial Virus (RSV) Study
The primary objectives of the study are: To assess the safety profile of each dose of the study product after each and any administration in all infants and toddlers regardless
- 14 views
- 28 Jul, 2021
- 17 locations
Cognitive Fitness for Depression in Older Adults
This research is being done to determine if computerized administered cognitive fitness activities will improve thinking and depression in older depressed adults who are being treated with antidepressants. The investigators are also interested in whether participating in the treatment will result in changes to brain activity measured with magnetic resonance …
- 0 views
- 23 Mar, 2021
- 1 location
Study to Evaluate the Safety Tolerability and Efficacy of BGE-175 in Participants 60 Years of Age and Hospitalized With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure
The primary objectives of this study are to evaluate the safety, tolerability, and efficacy of BGE-175 in participants 60 years of age hospitalized with documented COVID-19.
- 10 views
- 29 Mar, 2021
Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies
The study will determine Recommended Phase 2 Dose for all study drugs, based on the safety and tolerability of the following combinations: INCAGN02385 + INCAGN02390 and INCAGN02385 + INCAGN02390
- 0 views
- 04 Aug, 2020
- 3 locations